Authors:
KUBE R
SPLETTSTOESSER WR
WAGNER W
SEELHORST U
YU YH
TUNG C
BEAUMIER P
PRIEUR J
RAHIER G
SPIEGEL P
BOUTIER A
BROOKS TF
BURLEY CL
BOYD DD
MERCKER E
PENGEL K
Citation: R. Kube et al., HHC AEROACOUSTIC ROTOR TESTS IN THE GERMAN-DUTCH WIND-TUNNEL - IMPROVING PHYSICAL UNDERSTANDING AND PREDICTION CODES, Aerospace science and technology, 2(3), 1998, pp. 177-190
Authors:
BREITZ H
KNOX S
WEIDEN P
GORIS M
MURTHA A
BRYAN J
AXWORTHY D
SEILER C
SU FM
BEAUMIER P
RENO J
Citation: H. Breitz et al., PRETARGETED RADIOIMMUNOTHERAPY(TM) WITH ANTIBODY-STREPTAVIDIN AND Y-90 DOTA-BIOTIN (AVICIDIN(R)) - RESULT OF A DOSE-ESCALATION STUDY, The Journal of nuclear medicine, 39(5), 1998, pp. 272-272
Authors:
SU FM
BEAUMIER P
AXWORTHY D
RENO J
FISHER D
FRITZBERG A
Citation: Fm. Su et al., PRETARGETED RADIOIMMUNOTHERAPY IN TUMORED MICE USING AN IN-VIVO PB-212 BI-212 GENERATOR/, The Journal of nuclear medicine, 39(5), 1998, pp. 354-354
Citation: P. Beaumier et al., CFD DRAG AND POWER PREDICTION FOR A ROTOR IN HOVER OR FORWARD FLIGHT - FORMULATION AND FIRST APPLICATIONS, Journal of the American Helicopter Society, 42(4), 1997, pp. 327-336
Authors:
HEIDER KH
SPROLL M
SUSANI S
PATZELT E
BEAUMIER P
OSTERMANN E
AHORN H
ADOLF GR
Citation: Kh. Heider et al., CHARACTERIZATION OF A HIGH-AFFINITY MONOCLONAL-ANTIBODY SPECIFIC - FOR CD44V6 AS CANDIDATE FOR IMMUNOTHERAPY OF SQUAMOUS-CELL CARCINOMAS, Cancer immunology and immunotherapy, 43(4), 1996, pp. 245-253
Citation: Fm. Su et al., IN-111 Y-90 DUAL-ISOTOPE SCINTILLATION-COUNTING METHOD FOR PATIENT SAMPLES FROM PRETARGETED CANCER-THERAPY PHASE-I TRIAL/, The Journal of nuclear medicine, 37(5), 1996, pp. 636-636
Authors:
STEVENSON AJ
WEBER MP
TODI F
YOUNG L
BEAUMIER P
KACEW S
Citation: Aj. Stevenson et al., PLASMA ELIMINATION AND URINARY-EXCRETION OF PROCAINE AFTER ADMINISTRATION OF DIFFERENT PRODUCTS TO STANDARD-BRED MARES, Equine veterinary journal, 24(2), 1992, pp. 118-124